Zydus Life receives final USFDA approval for insomnia drug December 30, 2022 AutoBot News 0 The approval granted by the US Food and Drug Administration (USFDA) is to market Triazolam tablets of strengths 0.125 mg and 0.25 mg, the company said in a regulatory filing.